drugset / Trial / NCT02767219
The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a phase III randomised controlled pilot study which aims to assess the effectiveness of the use of bevacizumab in patients who have undergone trabeculectomy surgery, which appear to be showing early signs of failure.
Timeline
- Start
- 2016-05
- Primary completion
- 2019-02
- Completion
- 2019-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bevacizumab | Monoclonal antibody | — | Other |
| Subject | fluorouracil | Small molecule | — | Other |
| Background | Dexamethasone | Small molecule | 3.3 mg/ml | Other |